Direct purchasers seek final approval of Pfizer settlement in US EpiPen case
MLex Summary: Direct purchasers of EpiPens asked a US federal judge to grant final approval to their $50 million settlement with Pfizer to resolve allegations that it conspired to limit competitive...To view the full article, register now.
Already a subscriber? Click here to view full article